Free Trial

Vaxxinity (VAXX) SEC Filings & 10K Form

$0.09
+0.01 (+12.50%)
(As of 05/28/2024 ET)

Recent Vaxxinity SEC Filings

DateFilerForm TypeView
05/09/2024
3:24 PM
Vaxxinity (Filer)
Form 15-12G
05/09/2024
3:09 PM
Vaxxinity (Filer)
Form DEF 14C
05/02/2024
11:15 PM
Vaxxinity (Filer)
Form EFFECT
04/30/2024
3:46 PM
Vaxxinity (Filer)
Form S-8 POS
04/30/2024
3:35 PM
Vaxxinity (Filer)
Form S-8 POS
04/29/2024
4:06 PM
Vaxxinity (Filer)
Form 10-K/A
04/29/2024
3:46 PM
Vaxxinity (Filer)
Form PRE 14C
03/27/2024
3:18 PM
Vaxxinity (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/15/2024
3:15 PM
Vaxxinity (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2024
3:04 PM
Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2023
9:30 AM
Vaxxinity (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/30/2023
4:03 PM
Prime Movers Lab GP I LLC (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2023
4:13 PM
Prime Movers Lab GP I LLC (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2023
4:10 PM
Prime Movers Growth GP I LLC (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2023
3:20 PM
Prime Movers Growth GP I LLC (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2023
3:21 PM
Prime Movers Lab GP I LLC (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2023
6:53 AM
Vaxxinity (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/03/2023
3:31 PM
Paula Molina Rene (Reporting)
Vaxxinity (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2023
8:42 PM
Powchik Peter (Reporting)
Vaxxinity (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2023
8:40 PM
Ray Sumita (Reporting)
Vaxxinity (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2023
3:33 PM
Prime Movers Lab GP I LLC (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/28/2023
3:15 PM
Vaxxinity (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/22/2023
3:12 PM
Prime Movers Growth GP I LLC (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/22/2023
3:16 PM
Prime Movers Lab GP I LLC (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/14/2023
4:10 PM
Covaxx PML SPV 3 LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/14/2023
4:11 PM
COVAXX PML SPV 2 LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/14/2023
4:14 PM
Covaxx PML SPV 1 LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/14/2023
4:18 PM
Prime Movers Growth Fund I LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/14/2023
4:19 PM
Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2023
3:34 PM
Covaxx PML SPV 3 LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2023
3:24 PM
Covaxx PML SPV 1 LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2023
3:26 PM
Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2023
3:31 PM
COVAXX PML SPV 2 LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2023
3:18 PM
Prime Movers Growth Fund I LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2023
4:32 PM
Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2023
4:00 PM
Covaxx PML SPV 3 LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2023
4:01 PM
Prime Movers Growth Fund I LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2023
4:02 PM
Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2023
4:02 PM
Covaxx PML SPV 1 LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2023
4:12 PM
COVAXX PML SPV 2 LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2023
4:20 PM
Covaxx PML SPV 3 LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Did You Get Your Free Bitcoin Yet? (Ad)

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here
09/11/2023
3:52 PM
Prime Movers Growth Fund I LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2023
3:42 PM
Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/08/2023
5:05 PM
Prime Movers Lab Fund I LP (Reporting)
Sloss Dakin (Reporting)
Vaxxinity (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2023
4:33 PM
Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/08/2023
4:14 PM
Covaxx PML SPV 3 LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/08/2023
4:23 PM
Prime Movers Growth Fund I LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/08/2023
3:50 PM
COVAXX PML SPV 2 LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/07/2023
3:38 PM
Prime Movers Growth Fund I LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/07/2023
3:42 PM
Covaxx PML SPV 1 LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/07/2023
3:26 PM
COVAXX PML SPV 2 LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/07/2023
3:32 PM
Covaxx PML SPV 3 LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/07/2023
3:20 PM
Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/06/2023
3:13 PM
COVAXX PML SPV 2 LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/06/2023
3:14 PM
Covaxx PML SPV 3 LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/06/2023
3:15 PM
Covaxx PML SPV 1 LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/06/2023
3:16 PM
Prime Movers Growth Fund I LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/06/2023
3:18 PM
Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2023
11:15 PM
Vaxxinity (Filer)
Form EFFECT
08/09/2023
6:30 AM
Vaxxinity (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2023
6:31 AM
Vaxxinity (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/26/2023
5:31 PM
Powchik Peter (Reporting)
Vaxxinity (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
5:32 PM
Diamandis Peter (Reporting)
Vaxxinity (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
5:34 PM
TOLEDANO GABRIELLE B (Reporting)
Vaxxinity (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
5:35 PM
Eade Katherine A. (Reporting)
Vaxxinity (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
5:37 PM
Ogilvie Landon E (Reporting)
Vaxxinity (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
5:37 PM
Smith James Alan (Reporting)
Vaxxinity (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
5:39 PM
HORNIG GEORGE R (Reporting)
Vaxxinity (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:30 PM
Vaxxinity (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:VAXX) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners